U.S. Wireless Telecom Stock News

NasdaqGS:CYTK
NasdaqGS:CYTKBiotechs

Is It Too Late To Consider Cytokinetics (CYTK) After Its 62% One-Year Surge?

Investors may be wondering whether Cytokinetics at around US$65.48 is still offering value, or if most of the upside is already reflected in the price. The stock has returned 0.1% over the last week, 9.1% over the past 30 days, 6.1% year to date and 62.4% over the last year, with longer term returns of 73.0% over 3 years and 148.1% over 5 years. Recent coverage has focused on Cytokinetics as a biotech name that investors are watching closely, with attention on how its pipeline and...
NYSE:CNC
NYSE:CNCHealthcare

Is It Time To Reassess Centene (CNC) After Its Recent Share Price Rebound

Investors may be asking whether Centene's current share price reflects its true worth, or if the recent weakness could be setting up a more interesting entry point. Centene's stock closed at US$41.09, with a 5.4% gain over the last 7 days and a 24.6% gain over the last 30 days, while returns sit at a 1.7% decline year to date and a 33.3% decline over the past year. Recent news around Centene has focused on its position in managed care and healthcare services, as investors weigh how policy,...
NYSE:CPAY
NYSE:CPAYDiversified Financial

Corpay’s Toulouse FC Deal And What It Could Mean For NYSE CPAY

Corpay Cross-Border, part of NYSE:CPAY, has entered a new partnership with Toulouse Football Club as the club's Official FX Supplier. The agreement extends Corpay's reach in European football, following its previously announced relationship with AC Milan. The deal focuses on supporting Toulouse FC's international payment and currency risk management needs. For readers tracking NYSE:CPAY, this Toulouse FC partnership adds another high profile sports relationship to Corpay's cross border...
NasdaqGS:GSHD
NasdaqGS:GSHDInsurance

Goosehead Insurance (GSHD) Margin Pressure Tests Bullish Growth Narrative Ahead Of Q1 2026

Goosehead Insurance (GSHD) has just posted its latest update for Q1 2026, with recent quarterly numbers showing Q4 2025 revenue of US$105.1 million and basic EPS of US$0.50 on net income of US$12.4 million. Over the past reported periods, revenue has moved from US$77.8 million in Q3 2024 to US$93.7 million in Q4 2024 and then to US$105.1 million in Q4 2025, while basic EPS over the same snapshot has been US$0.31, US$0.60 and US$0.50 respectively. This gives a clearer sense of how the top line...
NYSE:PATH
NYSE:PATHSoftware

Is It Time To Reassess UiPath (PATH) After Its Recent Share Price Slide

If you are wondering whether UiPath's current share price fairly reflects its prospects, you are in the right place for a clear look at what the numbers say about value. UiPath recently closed at US$10.09, with returns of a 4.9% decline over 7 days, an 8.9% decline over 30 days, a 36.5% decline year to date and a 10.9% decline over the last year, which many readers may see as a signal to reassess both risk and potential. Recent coverage has focused on UiPath's position in automation software...
NasdaqGS:PRVA
NasdaqGS:PRVAHealthcare

Stronger-Than-Expected Earnings and Guidance Could Be A Game Changer For Privia Health Group (PRVA)

Earlier this month, Privia Health reported quarterly revenue and earnings that exceeded analyst expectations and raised its full-year revenue guidance, highlighting stronger operating performance across its 13-state and Washington, D.C. footprint. Beneath the headline beat, the combination of improved profitability and an upgraded outlook contrasts with earlier concerns about subscale operations and negative returns on capital. We’ll now examine how this stronger-than-expected earnings...
NasdaqGS:ROP
NasdaqGS:ROPSoftware

Roper Technologies (ROP) Margin Decline Tests Bullish AI Growth Narrative Heading Into Q1 2026

Q1 2026 results set the tone for Roper Technologies (ROP) Roper Technologies (ROP) opened Q1 2026 earnings season with Q4 2025 revenue of US$2,058.6 million and basic EPS of US$4.00, backed by net income of US$428.4 million. Over the last few quarters, the company has seen revenue move from US$1,764.6 million in Q3 2024 to US$2,058.6 million in Q4 2025, while basic EPS shifted from US$3.43 to US$4.00. This gives investors a clearer view of how the top line and EPS are trending into the latest...
NasdaqCM:IMNM
NasdaqCM:IMNMBiotechs

Immunome Desmoid Tumor Data And NDA Plan Test Growth Expectations

Immunome plans to present full Phase 3 RINGSIDE trial data for varegacestat in desmoid tumor patients at the 2026 ASCO Annual Meeting. The company expects to file a New Drug Application with the FDA for varegacestat after the ASCO presentation. The update highlights progress toward a potential new treatment option for this rare soft tissue tumor. For investors tracking Immunome, ticker NasdaqCM:IMNM, this update centers on a late stage program that could influence the company’s future...
NYSE:TAP
NYSE:TAPBeverage

Is It Time To Revisit Molson Coors (TAP) After Recent Share Price Weakness

If you are wondering whether Molson Coors Beverage is attractively priced at around US$42.87, the key is understanding what you are getting for that share price today. The stock has been under pressure over longer periods, with a 23.6% decline over the last year and a 9.6% drop year to date, although it has risen 4.2% over the past month while slipping 2.9% in the last week. Recent news flow around Molson Coors has focused on its position in the beverage sector and how investors are weighing...
NYSE:BWMX
NYSE:BWMXSpecialty Retail

Does Betterware de México's (BWMX) Profitability Jump Signal a Deeper Shift in Its Earnings Quality?

Betterware de México, S.A.P.I. de C.V. reported past first-quarter 2026 results with sales of MX$3,509.7 million, slightly above the prior year’s MX$3,499.15 million, and net income of MX$281.34 million versus MX$151.39 million. The sharp improvement in profit despite broadly flat revenue suggests the company has recently become more efficient in converting sales into earnings. Next, we’ll examine how this stronger profitability trend could influence Betterware de México’s investment...
NYSE:TRV
NYSE:TRVInsurance

Travelers Tests AI Distribution With Simply Business Small Business App

Simply Business, a subsidiary of Travelers Companies, has launched an AI powered insurance app for small businesses in the US. The new app, available on ChatGPT, is designed to streamline the quoting process for small business insurance. The launch introduces a new use of artificial intelligence within Travelers Companies' global operations. Travelers Companies (NYSE:TRV) is adding a fresh technology angle to its profile with this new AI app from Simply Business. The move comes as the...
NasdaqGS:IRDM
NasdaqGS:IRDMTelecom

Iridium Communications (IRDM) High 37.8x P/E Tests Bullish Growth Narratives Ahead Of Q1 2026

Iridium Communications (IRDM) Q1 2026 earnings snapshot Iridium Communications (IRDM) has entered Q1 2026 with trailing 12 month revenue of US$871.7 million and basic EPS of US$1.07, backed by net income of US$114.4 million. The most recent reported quarter, Q4 2025, delivered revenue of US$212.9 million and basic EPS of US$0.24. Over the past six reported quarters, revenue has ranged between US$212.8 million and US$226.9 million, with quarterly basic EPS moving between US$0.21 and US$0.35...
NYSE:MAIR
NYSE:MAIRBuilding

A Look At Madison Air Solutions (MAIR) Valuation As Shares Build Short Term Momentum

Event overview and recent share performance Madison Air Solutions (MAIR) shares recently showed mixed short term moves, with a 1.2% decline over the past day and a 7.8% gain over the past week. This has drawn attention to how investors are pricing its air quality business. See our latest analysis for Madison Air Solutions. With a 7.8% year to date share price return at a current share price of $34.24, recent gains suggest improving short term momentum after a softer 1 day move, while the...
NYSE:KRP
NYSE:KRPOil and Gas

Has Kimbell Royalty Partners (KRP) Risen Too Far After 33% One Year Gain?

If you are wondering whether Kimbell Royalty Partners at around US$14.59 still offers value, the key question is how its current price lines up with its fundamentals and cash flows. The units have returned 1.0% over the last 7 days, around flat at 0.5% over 30 days, and are up 21.3% year to date and 33.0% over the past year, which may have shifted how some investors view its risk and reward profile. Recent attention on Kimbell Royalty Partners has focused on its role in the US energy sector...
NYSE:DD
NYSE:DDChemicals

DuPont Targets 2035 Sustainability As Market Weighs Digital Growth Potential

DuPont de Nemours (NYSE:DD) has set new 2035 Sustainability Goals centered on sustainable innovation, resilient operations, and community engagement. The company recently introduced an AI-enabled RO Operations Advisor tool aimed at optimizing industrial water treatment processes. DuPont also launched ultrapure fluid transfer assemblies aimed at biopharma manufacturing and healthcare production environments. For investors watching materials and specialty chemicals, these moves illustrate how...
NasdaqGS:DAKT
NasdaqGS:DAKTElectronic

US High Growth Tech Stocks To Watch In Your Portfolio

Over the last 7 days, the United States market has remained flat, yet it is up 30% over the past year with earnings forecast to grow by 16% annually. In this environment, identifying high growth tech stocks that align with these promising trends can be a valuable addition to a diversified portfolio.
NYSE:CMS
NYSE:CMSIntegrated Utilities

Is CMS Energy (CMS) Fairly Priced After Recent Share Price Softness?

If you are wondering whether CMS Energy at around US$76.62 is priced attractively or asking too much for its future prospects, you are in the right place. The stock has seen a 1.9% decline over the last 7 days, a 1.7% return over the past month, and sits on 8.8% year to date and 6.5% over the last year. These figures will shape how you think about both upside potential and risk. Over the past three years CMS Energy has delivered a 34.9% return, and over five years the return stands at 39.6%...
NYSE:WH
NYSE:WHHospitality

Wyndham Expands ECHO Suites And Dolce Brands To Broaden Fee Mix

Wyndham Hotels & Resorts (NYSE:WH) has opened its 20th ECHO Suites Extended Stay hotel, marking a key milestone for its extended stay brand. The company has also added three new Dolce by Wyndham properties in major U.S. travel destinations. These moves expand Wyndham’s presence in both extended stay and upscale, design led lodging categories. For investors watching NYSE:WH, these brand expansions sit alongside a share price of $86.44 and a 30 day return of 11.7%. The stock is also up 14.8%...
NasdaqGS:BLLN
NasdaqGS:BLLNHealthcare

April 2026's High Insider Ownership Growth Leaders

The United States market has been flat over the last week but has seen a significant rise of 30% over the past year, with earnings forecasted to grow by 16% annually. In such an environment, identifying growth companies with high insider ownership can be crucial for investors seeking to align their interests with company insiders who have a vested interest in long-term success.
NasdaqGS:DLTH
NasdaqGS:DLTHSpecialty Retail

3 Promising Penny Stocks With Market Caps Under $600M

The market has been flat over the last week, but it's up 30% over the past year, with earnings forecast to grow by 16% annually. For investors willing to explore beyond established giants, penny stocks can offer a unique blend of affordability and growth potential. Despite their vintage name, these smaller or newer companies can present compelling opportunities when backed by solid financials.
NasdaqGS:SFD
NasdaqGS:SFDFood

Dividend Stocks To Consider In April 2026

The United States market has experienced a flat trajectory over the past week, yet it has achieved an impressive 30% increase over the past year, with earnings projected to grow by 16% annually. In this dynamic environment, identifying dividend stocks that offer consistent income and potential for growth can be a strategic approach for investors seeking stability and returns.